China focused on meeting international API demand amid pandemic, say officials
China is stepping up its efforts to produce and ship active pharmaceutical ingredients (APIs), with a focus on meeting international demand, particularly for those showing potential to treat the COVID-19 disease, according to Chinese officials on Tuesday.
Overall export volumes of Chinese APIs so far in 2020 have decreased by 10-20% year-on-year due to the coronavirus pandemic, officials said at a press conference arranged by China’s State Council Information Office.
Xin Guobin, deputy minister of industry and information technology said the main cause of the export decline was a combination of greatly reduced sea freight and international shipping and increased transportation costs.
“International transportation has become a bottleneck for the supply of APIs,” he said.
He added that Chinese API production had stalled in January and February due to the impact of the epidemic, with some manufacturers stopping production, causing a shortfall in supply even before the logistics and transportation problems arose in March.
Xin said that while overall current Chinese API production levels were at 80% of normal levels, volumes of those with potential to fight COVID-19 were already higher than year-earlier yields.
He described the country’s production at the two major producers of the API chloroquine phosphate as “stable” and said one of them, Chongqing Kangle Pharmaceutical, had managed to export 4.9 tons of the API in five days.
Earlier this week, the US Food and Drug Administration approved chloroquine phosphate and hydroxychloroquine sulphate for use against COVID-19, following a few anecdotal studies showing possible benefits to relieve the acute respiratory symptoms of the disease.
China is the world’s largest producer of APIs with more than 1,500 manufacturers, producing around 3 million tons a year.
However, since the coronavirus pandemic erupted, other countries such as the US and India have emphasised the need to find alternative API suppliers or increase domestic production to reduce their exposure during unforeseen events such as COVID-19.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance